13F COMBINATION REPORT
Nan Fung Group Holdings Ltd
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0001012975-23-000084
Total Value
$145.1M
Positions
42
Other Managers
2
Confidential Omitted
No
Holdings (42)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KARUNA THERAPEUTICS INC | 48576A100 | 225,688 | $44.3M | 30.56% |
| 2 | ILLUMINA INC | ILMN | 119,196 | $24.1M | 16.61% |
| 3 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 368,665 | $20.3M | 14.00% |
| 4 | SEAGEN INC | SE | 47,096 | $6.1M | 4.17% |
| 5 | REPLIMUNE GROUP INC | REPL | 189,339 | $5.2M | 3.55% |
| 6 | EXSCIENTIA PLC | 30223G102 | 853,050 | $4.5M | 3.13% |
| 7 | XENON PHARMACEUTICALS INC | XENE | 114,380 | $4.5M | 3.11% |
| 8 | SOMALOGIC INC | 83444K105 | 1,696,558 | $4.3M | 2.93% |
| 9 | CHINOOK THERAPEUTICS INC | 16961L106 | 113,950 | $3.0M | 2.06% |
| 10 | RANI THERAPEUTICS HLDGS INC | RANI | 493,584 | $2.9M | 2.01% |
| 11 | INCYTE CORP | INCY | 34,391 | $2.8M | 1.90% |
| 12 | BEIGENE LTD | BEIGF | 12,022 | $2.6M | 1.82% |
| 13 | IVERIC BIO INC | 46583P102 | 111,984 | $2.4M | 1.65% |
| 14 | EARGO INC | 270087109 | 2,958,099 | $1.7M | 1.17% |
| 15 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,166,952 | $1.5M | 1.05% |
| 16 | AEROVATE THERAPEUTICS INC | 008064107 | 50,616 | $1.5M | 1.02% |
| 17 | MERUS N V | N5749R100 | 93,750 | $1.5M | 1.00% |
| 18 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 136,655 | $1.1M | 0.77% |
| 19 | EXELIXIS INC | EXEL | 64,200 | $1.0M | 0.71% |
| 20 | ENTRADA THERAPEUTICS INC | TRDA | 73,582 | $994,829 | 0.69% |
| 21 | RHYTHM PHARMACEUTICALS INC | RYTM | 32,520 | $946,982 | 0.65% |
| 22 | GALERA THERAPEUTICS INC | GRTX | 613,223 | $913,702 | 0.63% |
| 23 | BIOMARIN PHARMACEUTICAL INC | BMRN | 6,115 | $632,841 | 0.44% |
| 24 | DBV TECHNOLOGIES S A | DBVTF | 370,950 | $567,554 | 0.39% |
| 25 | FIBROGEN INC | 31572Q808 | 34,106 | $546,378 | 0.38% |
| 26 | TRAVERE THERAPEUTICS INC | TVTX | 25,606 | $538,494 | 0.37% |
| 27 | KALVISTA PHARMACEUTICALS INC | KALV | 78,720 | $532,147 | 0.37% |
| 28 | ASCENDIS PHARMA A/S | ASND | 4,168 | $509,038 | 0.35% |
| 29 | BIOMEA FUSION INC | BMEA | 60,000 | $505,800 | 0.35% |
| 30 | ACADIA PHARMACEUTICALS INC | ACAD | 29,984 | $477,345 | 0.33% |
| 31 | ALX ONCOLOGY HLDGS INC | ALXO | 41,950 | $472,777 | 0.33% |
| 32 | AFFIMED N V | N01045108 | 372,472 | $461,865 | 0.32% |
| 33 | ARGENX SE | ARGX | 1,110 | $420,501 | 0.29% |
| 34 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1,182 | $343,076 | 0.24% |
| 35 | GITLAB INC | GTLB | 6,910 | $313,990 | 0.22% |
| 36 | SATSUMA PHARMACEUTICALS INC | 80405P107 | 177,900 | $160,110 | 0.11% |
| 37 | KODIAK SCIENCES INC | KOD | 19,622 | $140,494 | 0.10% |
| 38 | ABCELLERA BIOLOGICS INC | ABCL | 12,521 | $126,838 | 0.09% |
| 39 | NURIX THERAPEUTICS INC | NRIX | 11,500 | $126,270 | 0.09% |
| 40 | SYNLOGIC INC | SYBX | 68,634 | $52,162 | 0.04% |
| 41 | CERUS CORP | CERS | 14,172 | $51,728 | 0.04% |
| 42 | INVITAE CORP | 46185L103 | 11,337 | $21,087 | 0.01% |